Vanderbilt Training Program in Academic Cancer Research

描述（由申请人提供）：抗癌进展包括我们提供优质癌症护理和支持临床试验研究的能力。然而，有一个训练有素的肿瘤学家/血液学家能够全面研究临床相关问题的显着短缺;成功的设计和临床试验，以改善预防，检测和治疗人类癌症的进行;最重要的是，实验室，诊所和社区之间的基础知识和新技术的翻译。成功的，独立的翻译癌症研究人员的发展需要足够的保护时间和强大的导师在丰富的研究环境和组织良好的培训计划。范德比尔特-英格拉姆癌症中心是范德比尔特医疗中心内的一个矩阵中心，由于其综合的癌症相关专业知识和资源，非常适合支持这样一个全面的培训计划。范德比尔特学术癌症研究培训计划的目标是培训和支持医学肿瘤学/血液学研究员，以确保他们成功地迎接学术医学肿瘤学/血液学各个方面的新挑战和机遇。候选人将从血液学和肿瘤学奖学金计划部门招募。被录取的申请人将参加一个为期两年的综合培训计划，包括两个培训轨道：（1）临床研究者轨道将侧重于临床试验和相关研究的开发和实施（2）医生-科学家轨道将侧重于实验室研究。完成任一培训课程的研究员将有资格获得ABIM医学肿瘤学和血液学亚专业认证。完成该计划后，学员将能够在协作团队环境中成功发挥作用，通过假设驱动的研究开发和领导独立的研究计划，获得同行评审的资助支持，通过演示文稿和同行评审期刊上的出版物交流他们的研究成果，并提供高质量的癌症护理。为了帮助确保成功，100%的计划教师有同行评审的癌症研究的支持，并积极进行临床和/或实验室为基础的癌症研究，一贯发表在最好的期刊上，已经证明了导师的能力，并积极管理成功的研究计划。正在请求每年为两个培训职位提供支助。

DESCRIPTION (provided by applicant): Progress against cancer includes our ability to provide quality cancer care and support research within clinical trials. However, there is a significant shortage of well-trained oncologists/hematologists capable of comprehensive study of clinically-relevant problems; successful design and conduct of clinical trials to improve prevention, detection and treatment of human cancer; and most importantly, the translation of fundamental knowledge and new technologies between the laboratory, clinic, and community. The development of successful, independent translational cancer investigators requires adequate protected time and a strong mentorship in a rich research environment and well organized training program. The Vanderbilt-lngram Cancer Center, a matrix center within Vanderbilt Medical Center, is well-suited to support such a comprehensive training program due to its integrated cancer-related expertise and resources. The objective of the Vanderbilt Training Program in Academic Cancer Research is to train and support medical oncology/hematology fellows to ensure their success to meet new challenges and opportunities in all aspects of academic medical oncology/hematology. Candidates will be recruited from the Division of Hematology and Oncology Fellowship Program. Applicants accepted will participate in a comprehensive two-year training program consisting of two training tracks: (1) Clinical-Investigator Track will focus on the development and conduct of clinical trials and associated correlative studies (2) Physician-Scientist Track will focus on laboratory-based research. Fellows who complete either training track will be eligible for ABIM subspecialty certification in medical oncology and hematology. Upon completion of the program, trainees will be able to successfully function in a collaborative team environment, develop and lead independent research programs through hypothesis-driven research, obtain peer-reviewed grant support, communicate their research findings through presentations and publication in peer-reviewed journals, and provide high quality cancer care. To help ensure success, 100% of the program faculty have peer-reviewed support for cancer research and are actively conducting clinical and/or laboratory-based cancer research, consistently published in the best journals, have demonstrated mentorship abilities, and actively manage successful research programs. Support is being requested for two training positions per year.